Exhibitor

Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biopharmaceutical companies. With over 30 years of experience, our expertise encompasses all development phases (I-IV), and complex therapeutic areas. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of bringing novel treatments to market.